Specifically, we investigated whether the systemically active mGlu4 PAMs, Lu AF21934 or ADX88178, reduced established dyskinesia in either the 6-OHDA-lesioned rat or MPTP-treated marmoset models of PD, when compared with amantadine. This evidence concerns the gene GRM4 and drug-induced dyskinesia.